2020
Managing rheumatic diseases during COVID-19
Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clinical Rheumatology 2020, 39: 3245-3254. PMID: 32895747, PMCID: PMC7476772, DOI: 10.1007/s10067-020-05387-8.Peer-Reviewed Original ResearchConceptsAutoimmune rheumatic diseasesRheumatic diseasesImmunosuppressive agentsRheumatology practiceCOVID-19Multisystem autoimmune rheumatic diseaseLong-term complicationsCOVID-19 patientsCoronavirus disease 2019 (COVID-19) pandemicCOVID-19 infectionDisease 2019 pandemicMode of spreadImmunosuppressant managementImmunosuppressant medicationsViral illnessOrgan failureClinical featuresAutoimmune diseasesSerious infectionsTreatment optionsEffective vaccineImmune systemMedicationsDiseasePatients
2014
Amyloid Beta-Related Angiitis—A Case Report and Comprehensive Review of Literature of 94 Cases
Danve A, Grafe M, Deodhar A. Amyloid Beta-Related Angiitis—A Case Report and Comprehensive Review of Literature of 94 Cases. Seminars In Arthritis And Rheumatism 2014, 44: 86-92. PMID: 24636849, DOI: 10.1016/j.semarthrit.2014.02.001.Peer-Reviewed Original ResearchConceptsCerebral amyloid angiopathyPrimary central nervous system vasculitisE4/E4 genotypeCentral nervous system vasculitisClinical featuresAmyloid angiopathyMRI findingsBrain biopsyCase reportE4 genotypeAmyloid betaSusceptibility-weighted imagesCortico-subcortical junctionPresence of microbleedsFocal neurological deficitsFluid attenuation inversion recovery (FLAIR) imagesPrimary CNS vasculitisCharacteristic MRI findingsInversion recovery imagesCNS vasculitisReview of literatureAdditional immunosuppressantsGranulomatous vasculitisImmunosuppressant therapyNeurological deficits